Nikki, what's misleading about tagging a 50% drop in predicted top value as a "downgrade"?
And the only MSB investors who could take courage from this are those who got in below $4.50. Not me, by a long shot.
Anyway, I am a fundamental investor and do agree with you that nothing has happened to diminish the potential of the company apart from possible rough times if cash gets too low before revenue kicks in. BP has been so wrong so often in biotech that I'm not discouraged by their $ predictions. Hanging in.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.73 |
Change
0.025(1.47%) |
Mkt cap ! $2.207B | |||
| Open | High | Low | Value | Volume |
| $1.68 | $1.73 | $1.64 | $3.587M | 2.131M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1827 | $1.83 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.56 | 877 | 3 |
View Market Depth
| Last trade - 15.59pm 16/07/2025 (20 minute delay) ? |
| MSB (ASX) Chart |